Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-14

FDA Approved: BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves the original ANDA for a triple-ingredient cough/cold product containing brompheniramine, pseudoephedrine, and dextromethorphan from Ascend Laborato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN (brompheniramine, pseudoephedrine, dextromethorphan)

Snippet

ORIG AP for BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN (BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN)